Literature DB >> 12799487

The chemical bases of the various AIDS epidemics: recreational drugs, anti-viral chemotherapy and malnutrition.

Peter Duesberg1, Claus Koehnlein, David Rasnick.   

Abstract

In 1981 a new epidemic of about two-dozen heterogeneous diseases began to strike non-randomly growing numbers of male homosexuals and mostly male intravenous drug users in the US and Europe. Assuming immunodeficiency as the common denominator the US Centers for Disease Control (CDC) termed the epidemic, AIDS, for acquired immunodeficiency syndrome. From 1981-1984 leading researchers including those from the CDC proposed that recreational drug use was the cause of AIDS, because of exact correlations and of drug-specific diseases. However, in 1984 US government researchers proposed that a virus, now termed human immunodeficiency virus (HIV), is the cause of the non-random epidemics of the US and Europe but also of a new, sexually random epidemic in Africa. The virus-AIDS hypothesis was instantly accepted, but it is burdened with numerous paradoxes, none of which could be resolved by 2003: Why is there no HIV in most AIDS patients, only antibodies against it? Why would HIV take 10 years from infection to AIDS? Why is AIDS not self-limiting via antiviral immunity? Why is there no vaccine against AIDS? Why is AIDS in the US and Europe not random like other viral epidemics? Why did AIDS not rise and then decline exponentially owing to antiviral immunity like all other viral epidemics? Why is AIDS not contagious? Why would only HIV carriers get AIDS who use either recreational or anti-HIV drugs or are subject to malnutrition? Why is the mortality of HIV-antibody-positives treated with anti-HIV drugs 7-9%, but that of all (mostly untreated) HIV-positives globally is only 1.4%? Here we propose that AIDS is a collection of chemical epidemics, caused by recreational drugs, anti-HIV drugs, and malnutrition. According to this hypothesis AIDS is not contagious, not immunogenic, not treatable by vaccines or antiviral drugs, and HIV is just a passenger virus. The hypothesis explains why AIDS epidemics strike non-randomly if caused by drugs and randomly if caused by malnutrition, why they manifest in drug- and malnutrition-specific diseases, and why they are not self-limiting via anti-viral immunity. The hypothesis predicts AIDS prevention by adequate nutrition and abstaining from drugs, and even cures by treating AIDS diseases with proven medications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799487     DOI: 10.1007/BF02705115

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  194 in total

1.  Global AIDS surveillance. Part II.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2001-12-14

2.  Virology. Old guard urges virologists to go back to basics.

Authors:  M Enserink
Journal:  Science       Date:  2001-07-06       Impact factor: 47.728

3.  AIDS and intravenous drug use: the real heterosexual epidemic.

Authors:  A R Moss
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-14

4.  AIDS in Africa: an epidemiologic paradigm.

Authors:  T C Quinn; J M Mann; J W Curran; P Piot
Journal:  Science       Date:  1986-11-21       Impact factor: 47.728

5.  Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group.

Authors:  M A Fischl; D D Richman; D M Causey; M H Grieco; Y Bryson; D Mildvan; O L Laskin; J E Groopman; P A Volberding; R T Schooley
Journal:  JAMA       Date:  1989-11-03       Impact factor: 56.272

6.  Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.

Authors:  R S Hogg; B Yip; K J Chan; E Wood; K J Craib; M V O'Shaughnessy; J S Montaner
Journal:  JAMA       Date:  2001-11-28       Impact factor: 56.272

7.  HIV and the aetiology of AIDS.

Authors:  P Duesberg
Journal:  Lancet       Date:  1993-04-10       Impact factor: 79.321

8.  Correlates of the rate of decline of CD4+ lymphocytes among injection drug users infected with the human immunodeficiency virus.

Authors:  P Alcabes; E E Schoenbaum; R S Klein
Journal:  Am J Epidemiol       Date:  1993-05-01       Impact factor: 4.897

Review 9.  Clotting factor concentrates and immune function in haemophilic patients.

Authors:  K Hoots; D Canty
Journal:  Haemophilia       Date:  1998-09       Impact factor: 4.287

10.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

View more
  2 in total

1.  Questioning the HIV-AIDS Hypothesis: 30 Years of Dissent.

Authors:  Patricia Goodson
Journal:  Front Public Health       Date:  2014-09-23

2.  Lessons from previous predictions of HIV/AIDS in the United States and Japan: epidemiologic models and policy formulation.

Authors:  Hiroshi Nishiura
Journal:  Epidemiol Perspect Innov       Date:  2007-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.